Amana Growth ETF (AMGR)
Live price chart, market sentiment, and community perspectives for Amana Growth ETF (NASDAQ: AMGR).
Live price chart, market sentiment, and community perspectives for Amana Growth ETF (NASDAQ: AMGR).
On our desk, we are closely monitoring AMGR's liquidity profile. With total assets under management lingering under $5 million—specifically around $3.69M to $4.63M—and daily volumes frequently failing to crack 11,000 shares, execution risk is non-trivial. Even though the top 10 holdings feature strong large-growth names like Apple at 7.72% and NVIDIA at 6.98%, the micro-cap AUM footprint means institutional position sizing must remain heavily constrained until secondary market depth improves.
From a risk management standpoint, the 0.61% expense ratio strikes me as steep for a fund with an inception date in late June 2026 and only about 31 total holdings. While the top holdings heavily concentrate risk into the technology sector—including Broadcom, Alphabet, Taiwan Semiconductor, ASML, and Microsoft—the lack of established trading history forces us to use wider bid-ask spreads in our quantitative risk models until historical variance smooths out.
Watching the price action near its 52-week range—trading between roughly $24.68 and $26.07—market sentiment feels tentative. WalletInvestor models list a C historical index grade, reflecting early-stage volatility and sparse historical performance data. Traders on the floor are treating it more like a specialized equity sleeve rather than a core portfolio holding due to the light 240,000 total shares outstanding.
When evaluating compliance with the fund's mandate, we note that Saturna Capital Corporation acts as the issuer under the Amana Mutual Funds Trust framework. The fund operates as a non-diversified equity vehicle focusing on large growth, with nearly 57.4% of its assets tied up in its top ten holdings alone. Analysts interviewing for portfolio positioning roles need to understand how ethical or value-aligned screens interact with high-conviction tech weightings like Eli Lilly in healthcare and AMD.
As a hedge fund PM, I appreciate the purity of the large growth exposure—overweighting semiconductors and mega-cap tech like Apple and NVIDIA gives it strong secular momentum capture. However, the tiny asset base means creations and redemptions could cause tracking error during market stress. We are keeping AMGR on our watchlist until AUM scales past the $50 million threshold.
Explore plasma cleansing, somatic organ swaps, and BCI.